Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease

Roser Torra, Miguel Viribay, Dolores Tellería, Cèlia Badenas, Michael Watson, Peter C Harris, Alejandro Darnell, José L. San Millán

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background. Autosomal dominant polycystic kidney disease (ADPKD) is genetically heterogeneous, with at least three chromosomal loci accounting for the disease. Mutations in the PKD2 gene on the long arm of chromosome 4 are expected to be responsible for approximately 15% of cases of ADPKD. Methods. We report a systematic screening for mutations covering the 15 exons of the PKD2 gene in eight unrelated families with ADPKD type 2, using the heteroduplex technique. Results. Seven novel mutations were identified and characterized that, together with the previously described changes, amount to a detection rate of 85% in the population studied. The newly described mutations are two nonsense mutations, a 1 bp deletion, a 1 bp insertion, a mutation that involves both a substitution and a deletion (2511AG→C), a complex mutation in exon 6 consisting of a simultaneous 7 bp inversion and a 4 bp deletion, and the last one is a G→C transversion that may be a missense mutation. Most of these mutations are expected to lead to the formation of shorter truncated proteins lacking the carboxyl terminus of PKD2. We have also characterized a frequent polymorphism, Arg-Pro, at codon 28 in this gene. The clinical features of these PKD2 patients are similar to the previously described, with the mean age of end-stage renal disease being 75.5 years (SE ± 3.8 years). Conclusions. Our results confirm that many different mutations are likely to be responsible for the disease and that most pathogenic defects probably are point or small changes in the coding region of the gene.

Original languageEnglish (US)
Pages (from-to)28-33
Number of pages6
JournalKidney International
Volume56
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Autosomal Dominant Polycystic Kidney
Mutation
Genes
arginylproline
Exons
Chromosomes, Human, Pair 4
Nonsense Codon
Insertional Mutagenesis
Missense Mutation
Codon
Chronic Kidney Failure
Population

Keywords

  • ADPKD
  • Cysts
  • Gene mutations
  • Heteroduplex
  • PKD2

ASJC Scopus subject areas

  • Nephrology

Cite this

Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease. / Torra, Roser; Viribay, Miguel; Tellería, Dolores; Badenas, Cèlia; Watson, Michael; Harris, Peter C; Darnell, Alejandro; San Millán, José L.

In: Kidney International, Vol. 56, No. 1, 1999, p. 28-33.

Research output: Contribution to journalArticle

Torra, R, Viribay, M, Tellería, D, Badenas, C, Watson, M, Harris, PC, Darnell, A & San Millán, JL 1999, 'Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease', Kidney International, vol. 56, no. 1, pp. 28-33. https://doi.org/10.1046/j.1523-1755.1999.00534.x
Torra, Roser ; Viribay, Miguel ; Tellería, Dolores ; Badenas, Cèlia ; Watson, Michael ; Harris, Peter C ; Darnell, Alejandro ; San Millán, José L. / Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease. In: Kidney International. 1999 ; Vol. 56, No. 1. pp. 28-33.
@article{cc5f083df88c44429c904ddaaa4a7414,
title = "Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease",
abstract = "Background. Autosomal dominant polycystic kidney disease (ADPKD) is genetically heterogeneous, with at least three chromosomal loci accounting for the disease. Mutations in the PKD2 gene on the long arm of chromosome 4 are expected to be responsible for approximately 15{\%} of cases of ADPKD. Methods. We report a systematic screening for mutations covering the 15 exons of the PKD2 gene in eight unrelated families with ADPKD type 2, using the heteroduplex technique. Results. Seven novel mutations were identified and characterized that, together with the previously described changes, amount to a detection rate of 85{\%} in the population studied. The newly described mutations are two nonsense mutations, a 1 bp deletion, a 1 bp insertion, a mutation that involves both a substitution and a deletion (2511AG→C), a complex mutation in exon 6 consisting of a simultaneous 7 bp inversion and a 4 bp deletion, and the last one is a G→C transversion that may be a missense mutation. Most of these mutations are expected to lead to the formation of shorter truncated proteins lacking the carboxyl terminus of PKD2. We have also characterized a frequent polymorphism, Arg-Pro, at codon 28 in this gene. The clinical features of these PKD2 patients are similar to the previously described, with the mean age of end-stage renal disease being 75.5 years (SE ± 3.8 years). Conclusions. Our results confirm that many different mutations are likely to be responsible for the disease and that most pathogenic defects probably are point or small changes in the coding region of the gene.",
keywords = "ADPKD, Cysts, Gene mutations, Heteroduplex, PKD2",
author = "Roser Torra and Miguel Viribay and Dolores Teller{\'i}a and C{\`e}lia Badenas and Michael Watson and Harris, {Peter C} and Alejandro Darnell and {San Mill{\'a}n}, {Jos{\'e} L.}",
year = "1999",
doi = "10.1046/j.1523-1755.1999.00534.x",
language = "English (US)",
volume = "56",
pages = "28--33",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease

AU - Torra, Roser

AU - Viribay, Miguel

AU - Tellería, Dolores

AU - Badenas, Cèlia

AU - Watson, Michael

AU - Harris, Peter C

AU - Darnell, Alejandro

AU - San Millán, José L.

PY - 1999

Y1 - 1999

N2 - Background. Autosomal dominant polycystic kidney disease (ADPKD) is genetically heterogeneous, with at least three chromosomal loci accounting for the disease. Mutations in the PKD2 gene on the long arm of chromosome 4 are expected to be responsible for approximately 15% of cases of ADPKD. Methods. We report a systematic screening for mutations covering the 15 exons of the PKD2 gene in eight unrelated families with ADPKD type 2, using the heteroduplex technique. Results. Seven novel mutations were identified and characterized that, together with the previously described changes, amount to a detection rate of 85% in the population studied. The newly described mutations are two nonsense mutations, a 1 bp deletion, a 1 bp insertion, a mutation that involves both a substitution and a deletion (2511AG→C), a complex mutation in exon 6 consisting of a simultaneous 7 bp inversion and a 4 bp deletion, and the last one is a G→C transversion that may be a missense mutation. Most of these mutations are expected to lead to the formation of shorter truncated proteins lacking the carboxyl terminus of PKD2. We have also characterized a frequent polymorphism, Arg-Pro, at codon 28 in this gene. The clinical features of these PKD2 patients are similar to the previously described, with the mean age of end-stage renal disease being 75.5 years (SE ± 3.8 years). Conclusions. Our results confirm that many different mutations are likely to be responsible for the disease and that most pathogenic defects probably are point or small changes in the coding region of the gene.

AB - Background. Autosomal dominant polycystic kidney disease (ADPKD) is genetically heterogeneous, with at least three chromosomal loci accounting for the disease. Mutations in the PKD2 gene on the long arm of chromosome 4 are expected to be responsible for approximately 15% of cases of ADPKD. Methods. We report a systematic screening for mutations covering the 15 exons of the PKD2 gene in eight unrelated families with ADPKD type 2, using the heteroduplex technique. Results. Seven novel mutations were identified and characterized that, together with the previously described changes, amount to a detection rate of 85% in the population studied. The newly described mutations are two nonsense mutations, a 1 bp deletion, a 1 bp insertion, a mutation that involves both a substitution and a deletion (2511AG→C), a complex mutation in exon 6 consisting of a simultaneous 7 bp inversion and a 4 bp deletion, and the last one is a G→C transversion that may be a missense mutation. Most of these mutations are expected to lead to the formation of shorter truncated proteins lacking the carboxyl terminus of PKD2. We have also characterized a frequent polymorphism, Arg-Pro, at codon 28 in this gene. The clinical features of these PKD2 patients are similar to the previously described, with the mean age of end-stage renal disease being 75.5 years (SE ± 3.8 years). Conclusions. Our results confirm that many different mutations are likely to be responsible for the disease and that most pathogenic defects probably are point or small changes in the coding region of the gene.

KW - ADPKD

KW - Cysts

KW - Gene mutations

KW - Heteroduplex

KW - PKD2

UR - http://www.scopus.com/inward/record.url?scp=0033000303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033000303&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.1999.00534.x

DO - 10.1046/j.1523-1755.1999.00534.x

M3 - Article

C2 - 10411676

AN - SCOPUS:0033000303

VL - 56

SP - 28

EP - 33

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -